Report cover image

Biotechnology

Published May 01, 2026
Length 570 Pages
SKU # GJOB21177373

Description

Global Biotechnology Market to Reach US$4.3 Trillion by 2032

The global market for Biotechnology estimated at US$1.8 Trillion in the year 2025, is expected to reach US$4.3 Trillion by 2032, growing at a CAGR of 12.9% over the analysis period 2025-2032. Biopharmaceuticals Type, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$1.3 Trillion by the end of the analysis period. Growth in the Bioprocess Equipment & Consumables Type segment is estimated at 14.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$567.6 Billion While China is Forecast to Grow at 17.6% CAGR

The Biotechnology market in the U.S. is estimated at US$567.6 Billion in the year 2025. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Trillion by the year 2032 trailing a CAGR of 17.6% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.9% and 12.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.7% CAGR.

Global Biotechnology Market - Key Trends & Drivers Summarized

How Is Biotechnology Revolutionizing Medicine and Agriculture?

Biotechnology is fundamentally transforming the fields of medicine, agriculture, and industrial processes by harnessing biological systems to develop innovative products and solutions. In medicine, biotechnology has enabled the development of life-saving therapies such as gene editing, monoclonal antibodies, and vaccines. It is also pivotal in advancing personalized medicine, where treatments are tailored to an individual’s genetic makeup. In agriculture, biotechnology has led to the development of genetically modified crops that offer higher yields, pest resistance, and improved nutritional content, helping to address global food security challenges. The role of biotechnology extends to industrial applications, where bio-based products and processes are replacing traditional chemical-based methods, fostering more sustainable manufacturing practices.

What Technological Advancements Are Shaping the Future of Biotechnology?

Technological advancements such as CRISPR gene-editing, synthetic biology, and biomanufacturing are at the forefront of shaping the future of biotechnology. CRISPR, in particular, has revolutionized genetic research by enabling precise modifications to DNA, opening new possibilities in curing genetic diseases, improving crop traits, and creating more efficient biofuels. Synthetic biology, which involves designing new biological components or systems, is driving innovation in fields like bioengineering, where microbes are engineered to produce everything from pharmaceuticals to bio-based plastics. Meanwhile, biomanufacturing techniques, such as continuous manufacturing and the use of single-use systems, are enhancing the scalability and efficiency of producing biologic drugs and other biotech products.

What Sectors Are Driving Biotechnology Growth?

The biotechnology market spans several key sectors, including healthcare, agriculture, and industrial biotechnology. In healthcare, the demand for biologic drugs, gene therapies, and personalized medicine is driving significant investment in biotech research and development. In agriculture, the adoption of genetically modified organisms (GMOs) and bio-based fertilizers and pesticides is helping to meet the global demand for sustainable food production. Industrial biotechnology is also witnessing rapid growth, particularly in the production of biofuels, biodegradable plastics, and enzymes used in manufacturing processes. The environmental benefits of biotech solutions, especially in reducing carbon footprints and minimizing chemical waste, are further expanding its applications across industries.

What Factors Are Driving Growth?

The growth in the biotechnology market is driven by several factors, including advancements in genetic engineering technologies, increasing investments in healthcare R&D, and the growing need for sustainable agricultural solutions. The rise of personalized medicine and the demand for biologic drugs are key drivers in the healthcare sector, while the need for more resilient and sustainable crops is boosting the agricultural biotech market. Additionally, the industrial sector is experiencing growth in bio-based production methods as companies aim to reduce environmental impact. The regulatory support for biotech innovations and the increasing public acceptance of GMOs and biologic therapies are further contributing to market expansion.

SCOPE OF STUDY:

The report analyzes the Biotechnology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Application (BioIndustrial, Bioinformatics, BioAgriculture, Biopharmacy, Other Applications); Technology (DNA Sequencing Market, Fermentation Market, Cell Based Assay Market, Nanobiotechnology Market, Chromatography Market, PCR Technology Market, Tissue Engineering and Regeneration Market, Other Technologies)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Merck KgaA
  • PerkinElmer, Inc.
  • QIAGEN GmbH
  • Thermo Fisher Scientific, Inc.


Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Table of Contents

570 Pages
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
Biotechnology – Global Key Competitors Percentage Market Share in 2026 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Biotechnology in Drug Development and Personalized Medicine
Technological Innovations in CRISPR, Gene Editing, and Synthetic Biology
Growing Applications of Biotechnology in Agriculture for GMO Crops and Biofertilizers
Advancements in Biomanufacturing Processes Driving Efficiency and Scalability
Expanding Role of Biotechnology in Environmental Sustainability and Biofuels
Increasing Investments in Healthcare and Biopharmaceutical Research & Development
Rising Adoption of Biotechnology in Diagnostics and Precision Medicine
Opportunities for Biotechnology Expansion in Emerging Markets
Growing Focus on Biotechnological Solutions to Address Climate Change and Global Food Security
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 2: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 3: World 13-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 4: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 5: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 6: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 7: World Biotechnology Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
TABLE 8: World Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 9: World Historic Review for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 10: World 13-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
TABLE 11: World Recent Past, Current & Future Analysis for Biopharmaceuticals Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 12: World Historic Review for Biopharmaceuticals Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 13: World 13-Year Perspective for Biopharmaceuticals Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 14: World Recent Past, Current & Future Analysis for Bioprocess Equipment & Consumables Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 15: World Historic Review for Bioprocess Equipment & Consumables Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 16: World 13-Year Perspective for Bioprocess Equipment & Consumables Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 17: World Recent Past, Current & Future Analysis for Reagents & Kits Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 18: World Historic Review for Reagents & Kits Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 19: World 13-Year Perspective for Reagents & Kits Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 20: World Recent Past, Current & Future Analysis for Bioservices Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 21: World Historic Review for Bioservices Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 22: World 13-Year Perspective for Bioservices Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 23: World Recent Past, Current & Future Analysis for Bioinformatics Platforms & Software Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 24: World Historic Review for Bioinformatics Platforms & Software Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 25: World 13-Year Perspective for Bioinformatics Platforms & Software Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 26: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 27: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 28: World 13-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 29: World Recent Past, Current & Future Analysis for DNA Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 30: World Historic Review for DNA Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 31: World 13-Year Perspective for DNA Sequencing Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 32: World Recent Past, Current & Future Analysis for Nanobiotechnology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 33: World Historic Review for Nanobiotechnology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 34: World 13-Year Perspective for Nanobiotechnology Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 35: World Recent Past, Current & Future Analysis for Tissue Engineering & Regeneration Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 36: World Historic Review for Tissue Engineering & Regeneration Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 37: World 13-Year Perspective for Tissue Engineering & Regeneration Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 38: World Recent Past, Current & Future Analysis for PCR Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 39: World Historic Review for PCR Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 40: World 13-Year Perspective for PCR Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 41: World Recent Past, Current & Future Analysis for Chromatography Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 42: World Historic Review for Chromatography Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 43: World 13-Year Perspective for Chromatography Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 44: World Recent Past, Current & Future Analysis for Gene Amplification Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 45: World Historic Review for Gene Amplification Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 46: World 13-Year Perspective for Gene Amplification Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 47: World Recent Past, Current & Future Analysis for Synthetic Biology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 48: World Historic Review for Synthetic Biology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 49: World 13-Year Perspective for Synthetic Biology Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 50: World Recent Past, Current & Future Analysis for CRISPR & Gene-Editing Tools Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 51: World Historic Review for CRISPR & Gene-Editing Tools Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 52: World 13-Year Perspective for CRISPR & Gene-Editing Tools Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 53: World Recent Past, Current & Future Analysis for Biochips & Microarrays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 54: World Historic Review for Biochips & Microarrays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 55: World 13-Year Perspective for Biochips & Microarrays Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 56: World Recent Past, Current & Future Analysis for Health & Red Biotechnology Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 57: World Historic Review for Health & Red Biotechnology Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 58: World 13-Year Perspective for Health & Red Biotechnology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 59: World Recent Past, Current & Future Analysis for Food & Agriculture Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 60: World Historic Review for Food & Agriculture Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 61: World 13-Year Perspective for Food & Agriculture Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 62: World Recent Past, Current & Future Analysis for Industrial Processing Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 63: World Historic Review for Industrial Processing Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 64: World 13-Year Perspective for Industrial Processing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 65: World Recent Past, Current & Future Analysis for Environmental & Natural Resources Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 66: World Historic Review for Environmental & Natural Resources Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 67: World 13-Year Perspective for Environmental & Natural Resources Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 68: World Recent Past, Current & Future Analysis for Bioinformatics & Omics Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 69: World Historic Review for Bioinformatics & Omics Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 70: World 13-Year Perspective for Bioinformatics & Omics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 71: World Recent Past, Current & Future Analysis for Biopharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 72: World Historic Review for Biopharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 73: World 13-Year Perspective for Biopharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 74: World Recent Past, Current & Future Analysis for CMOs & CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 75: World Historic Review for CMOs & CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 76: World 13-Year Perspective for CMOs & CROs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 77: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 78: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 79: World 13-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 80: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 81: World Historic Review for Hospitals & Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 82: World 13-Year Perspective for Hospitals & Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 83: World Recent Past, Current & Future Analysis for Agricultural Corporations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 84: World Historic Review for Agricultural Corporations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 85: World 13-Year Perspective for Agricultural Corporations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 86: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 87: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 88: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
TABLE 89: USA Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 90: USA Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 91: USA 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 92: USA Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 93: USA Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 94: USA 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 95: USA Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 96: USA Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 97: USA 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 98: USA Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 99: USA Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 100: USA 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
CANADA
TABLE 101: Canada Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 102: Canada Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 103: Canada 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 104: Canada Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 105: Canada Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 106: Canada 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 107: Canada Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 108: Canada Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 109: Canada 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 110: Canada Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 111: Canada Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 112: Canada 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
JAPAN
Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
TABLE 113: Japan Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 114: Japan Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 115: Japan 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 116: Japan Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 117: Japan Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 118: Japan 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 119: Japan Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 120: Japan Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 121: Japan 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 122: Japan Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 123: Japan Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 124: Japan 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
CHINA
Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
TABLE 125: China Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 126: China Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 127: China 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 128: China Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 129: China Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 130: China 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 131: China Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 132: China Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 133: China 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 134: China Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 135: China Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 136: China 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
EUROPE
Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
TABLE 137: Europe Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 138: Europe Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 139: Europe 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 140: Europe Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 141: Europe Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 142: Europe 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 143: Europe Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 144: Europe Historic Review for Biotechnology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 145: Europe 13-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
TABLE 146: Europe Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 147: Europe Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 148: Europe 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 149: Europe Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 150: Europe Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 151: Europe 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
FRANCE
Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
TABLE 152: France Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 153: France Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 154: France 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 155: France Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 156: France Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 157: France 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 158: France Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 159: France Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 160: France 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 161: France Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 162: France Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 163: France 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
GERMANY
Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
TABLE 164: Germany Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 165: Germany Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 166: Germany 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 167: Germany Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 168: Germany Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 169: Germany 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 170: Germany Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 171: Germany Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 172: Germany 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 173: Germany Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 174: Germany Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 175: Germany 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
ITALY
TABLE 176: Italy Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 177: Italy Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 178: Italy 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 179: Italy Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 180: Italy Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 181: Italy 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 182: Italy Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 183: Italy Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 184: Italy 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 185: Italy Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 186: Italy Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 187: Italy 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
UNITED KINGDOM
Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
TABLE 188: UK Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 189: UK Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 190: UK 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 191: UK Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 192: UK Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 193: UK 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 194: UK Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 195: UK Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 196: UK 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 197: UK Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 198: UK Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 199: UK 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
SPAIN
TABLE 200: Spain Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 201: Spain Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 202: Spain 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 203: Spain Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 204: Spain Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 205: Spain 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 206: Spain Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 207: Spain Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 208: Spain 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 209: Spain Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 210: Spain Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 211: Spain 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
RUSSIA
TABLE 212: Russia Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 213: Russia Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 214: Russia 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 215: Russia Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 216: Russia Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 217: Russia 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 218: Russia Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 219: Russia Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 220: Russia 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 221: Russia Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 222: Russia Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 223: Russia 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
REST OF EUROPE
TABLE 224: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 225: Rest of Europe Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 226: Rest of Europe 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 227: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 228: Rest of Europe Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 229: Rest of Europe 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 230: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 231: Rest of Europe Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 232: Rest of Europe 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 233: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 234: Rest of Europe Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 235: Rest of Europe 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
AUSTRALIA
Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
TABLE 236: Latin America Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 237: Latin America Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 238: Latin America 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 239: Latin America Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 240: Latin America Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 241: Latin America 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 242: Latin America Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 243: Latin America Historic Review for Biotechnology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 244: Latin America 13-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
TABLE 245: Latin America Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 246: Latin America Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 247: Latin America 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 248: Latin America Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 249: Latin America Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 250: Latin America 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
ARGENTINA
TABLE 251: Argentina Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 252: Argentina Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 253: Argentina 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 254: Argentina Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 255: Argentina Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 256: Argentina 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 257: Argentina Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 258: Argentina Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 259: Argentina 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 260: Argentina Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 261: Argentina Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 262: Argentina 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
BRAZIL
TABLE 263: Brazil Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 264: Brazil Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 265: Brazil 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 266: Brazil Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 267: Brazil Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 268: Brazil 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 269: Brazil Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 270: Brazil Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 271: Brazil 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 272: Brazil Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 273: Brazil Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 274: Brazil 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
MEXICO
TABLE 275: Mexico Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 276: Mexico Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 277: Mexico 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 278: Mexico Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 279: Mexico Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 280: Mexico 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 281: Mexico Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 282: Mexico Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 283: Mexico 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 284: Mexico Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 285: Mexico Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 286: Mexico 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
REST OF LATIN AMERICA
TABLE 287: Rest of Latin America Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 288: Rest of Latin America Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 289: Rest of Latin America 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 290: Rest of Latin America Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 291: Rest of Latin America Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 292: Rest of Latin America 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 293: Rest of Latin America Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 294: Rest of Latin America Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 295: Rest of Latin America 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 297: Rest of Latin America Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 298: Rest of Latin America 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
MIDDLE EAST
Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
TABLE 299: Middle East Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 300: Middle East Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 301: Middle East 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 302: Middle East Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 303: Middle East Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 304: Middle East 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 305: Middle East Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 306: Middle East Historic Review for Biotechnology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 307: Middle East 13-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
TABLE 308: Middle East Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 309: Middle East Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 310: Middle East 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 311: Middle East Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 312: Middle East Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 313: Middle East 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
IRAN
TABLE 314: Iran Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 315: Iran Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 316: Iran 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 317: Iran Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 318: Iran Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 319: Iran 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 320: Iran Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 321: Iran Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 322: Iran 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 323: Iran Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 324: Iran Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 325: Iran 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
ISRAEL
TABLE 326: Israel Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 327: Israel Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 328: Israel 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 329: Israel Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 330: Israel Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 331: Israel 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 332: Israel Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 333: Israel Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 334: Israel 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 335: Israel Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 336: Israel Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 337: Israel 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
SAUDI ARABIA
TABLE 338: Saudi Arabia Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 339: Saudi Arabia Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 340: Saudi Arabia 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 341: Saudi Arabia Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 342: Saudi Arabia Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 343: Saudi Arabia 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 344: Saudi Arabia Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 345: Saudi Arabia Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 346: Saudi Arabia 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 348: Saudi Arabia Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 349: Saudi Arabia 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
UNITED ARAB EMIRATES
TABLE 350: UAE Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 351: UAE Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 352: UAE 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 353: UAE Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 354: UAE Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 355: UAE 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 356: UAE Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 357: UAE Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 358: UAE 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 359: UAE Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 360: UAE Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 361: UAE 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
REST OF MIDDLE EAST
TABLE 362: Rest of Middle East Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 363: Rest of Middle East Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 364: Rest of Middle East 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 365: Rest of Middle East Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 366: Rest of Middle East Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 367: Rest of Middle East 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 368: Rest of Middle East Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 369: Rest of Middle East Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 370: Rest of Middle East 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 372: Rest of Middle East Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 373: Rest of Middle East 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
AFRICA
Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
TABLE 374: Africa Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 375: Africa Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 376: Africa 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
TABLE 377: Africa Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 378: Africa Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 379: Africa 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 380: Africa Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 381: Africa Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 382: Africa 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
TABLE 383: Africa Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 384: Africa Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 385: Africa 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
IV. COMPETITION
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.